Filter Results:
(3,187)
Show Results For
- All HBS Web
(3,187)
- People (7)
- News (427)
- Research (2,373)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,951)
Show Results For
- All HBS Web
(3,187)
- People (7)
- News (427)
- Research (2,373)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,951)
- Web
Topics - HBS Working Knowledge
Industries (8) Goals and Objectives (18) Going Public (36) Goods and Commodities (7) Governance Compliance (4) Governance Controls (76) Governance (268) Governing Rules, Regulations, and Reforms (72) Governing and Advisory Boards (20)... View Details
- September 2019
- Case
Dementia Discovery Fund
By: Richard G. Hamermesh, Kathy Giusti and Sarah Gulick
The case is set in March 2019, and tells the story of the founding of the Dementia Discovery Fund (DDF). The idea for the fund began in 2015, when then-Prime Minister David Cameron spoke about the importance of making breakthroughs in dementia research, and pledged... View Details
Keywords: Venture Capital; Investment Funds; Mission and Purpose; Recruitment; Health Care and Treatment; Pharmaceutical Industry; Pharmaceutical Industry; Boston; Massachusetts; London; England
Hamermesh, Richard G., Kathy Giusti, and Sarah Gulick. "Dementia Discovery Fund." Harvard Business School Case 820-045, September 2019.
- 04 Sep 2001
- Research & Ideas
Is Government Just Stupid? How Bad Decisions Are Made
evaluating business leaders, most people judge them primarily by results: profitability, return to shareholders, innovation and so on. This is the more rational measure of effectiveness. An organization's overall health will generally... View Details
- Web
Business History - Faculty & Research
Chemical Industry, 1950s–1980s By: Geoffrey Jones and Christina Lubinski This article examines the evolution of corporate environmentalism in the West German chemical industry between the 1950s and the 1980s. It focuses on two companies,... View Details
Stefan H. Thomke
Stefan Thomke (sthomke@hbs.edu), an authority on the management of innovation, is the William Barclay Harding Professor of Business Administration at Harvard Business School. He has worked with firms on product, process, and... View Details
- July 2024
- Case
Living up to Purpose and Performance at Parker Hannifin
By: Hubert Joly, Alicia Dadlani and Martha Hostetter
In 2019, Parker Hannifin, one of the world’s largest manufacturers of motion and control technologies, did something unusual for an industrial company: it created a purpose statement. Even though it already had a clear business strategy and longstanding culture of... View Details
Keywords: Mission and Purpose; Health Pandemics; Leadership; Business or Company Management; Organizational Culture; Business Strategy; Communication Strategy; Manufacturing Industry; Manufacturing Industry; Cleveland; Ohio; United States
Joly, Hubert, Alicia Dadlani, and Martha Hostetter. "Living up to Purpose and Performance at Parker Hannifin." Harvard Business School Case 525-015, July 2024.
- 30 Nov 2021
- In Practice
What's the Role of Business in Confronting Climate Change?
The 26th annual United Nations Climate Change Conference of the Parties, also known as COP26, ended with a hard-fought pact that called on businesses and governments to meet their climate change goals faster. The event followed an August report by the Intergovernmental... View Details
Keywords: by Lynn Schenk and Dina Gerdeman
- 18 Jul 2023
- Research & Ideas
Will Global Demand for Oil Peak This Decade?
Is the globe’s thirst for oil finally topping out? A major international energy watcher says yes, predicting last month that demand for global oil for transport will peak around 2026, plateau for all uses by 2028, and possibly hit a zenith by the end of the decade.... View Details
- Web
Skydeck - Alumni
Airlines CEO Frank Lorenzo (MBA 1963) recounts the radical ideas and relentless negotiations that transformed the airline industry The Musts of 2024 Alumni recommendations from the year in media Solving the Underemployment Crisis More... View Details
- October 1982 (Revised May 1992)
- Case
Johnson & Johnson: The Tylenol Tragedy
In October 1982, Johnson & Johnson was confronted with a major crisis when seven deaths were attributed to poisoned Tylenol. The case reviews the facts as known a week after the incident occurred, and raises a wide range of questions regarding consumer behavior,... View Details
Keywords: Consumer Behavior; Corporate Social Responsibility and Impact; Competitive Strategy; Crisis Management; Health Care and Treatment; Pharmaceutical Industry
Greyser, Stephen A. "Johnson & Johnson: The Tylenol Tragedy." Harvard Business School Case 583-043, October 1982. (Revised May 1992.)
- 2013
- Working Paper
Increased Speed Equals Increased Wait: The Impact of a Reduction in Emergency Department Ultrasound Order Processing Time
By: Jillian Berry Jaeker, Anita L. Tucker and Michael H. Lee
We exploit an exogenous process change at two emergency departments (EDs) within a health system to test the theory that increasing capacity in a discretionary work setting increases wait times due to additional services being provided to customers as a consequence of... View Details
Keywords: Technology; Demand and Consumers; Service Delivery; Health Care and Treatment; Business Processes; Health Industry
Berry Jaeker, Jillian, Anita L. Tucker, and Michael H. Lee. "Increased Speed Equals Increased Wait: The Impact of a Reduction in Emergency Department Ultrasound Order Processing Time." Harvard Business School Working Paper, No. 14-033, October 2013.
- 06 Mar 2007
- First Look
First Look: March 6, 2007
Industries - 2006 (TN) Harvard Business School Note 207-097 No abstract available. The Chad-Cameroon Petroleum Development and Pipeline Project (D) Harvard Business School Supplement 207-087 Supplements the (A) case. Purchase this... View Details
Keywords: Martha Lagace
- 22 Oct 2014
- HBS Seminar
Koleman Strumpf, University of Kansas School of Business
- Web
Financial Accounting Online Course | HBS Online
key concepts and metrics in valuation, including time value of money, terminal value, and net present value. Highlights Forecasting: Metropolis Health Care IRR and Payback Period Industry Insights: Assessing... View Details
- November 2012 (Revised August 2014)
- Case
Cisco in 2012: Reorganizing for Efficiency and Flexibility
By: Ranjay Gulati, Alison Berkley Wagonfeld and Luciana Silvestri
In 2012, Cisco was under intense pressure to show results: growth in its core business was decelerating and a number of exploratory ventures and acquisitions had not proven as profitable as expected. CEO John Chambers vowed to restore the company's health in a way that... View Details
Keywords: Organizational Change and Adaptation; Restructuring; Adaptation; Performance Efficiency; Emerging Markets; Information Technology Industry
Gulati, Ranjay, Alison Berkley Wagonfeld, and Luciana Silvestri. "Cisco in 2012: Reorganizing for Efficiency and Flexibility." Harvard Business School Case 413-069, November 2012. (Revised August 2014.)
- December 2016
- Article
Selective Regulator Decoupling and Organizations' Strategic Responses
By: Jonas Heese, Ranjani Krishnan and Frank Moers
Organizations often respond to institutional pressures by symbolically adopting policies and procedures but decoupling them from actual practice. Literature has examined why organizations decouple from regulatory pressures. In this study, we argue that decoupling... View Details
Keywords: Regulator Leniency; Beneficence; Mispricing; Upcoding; Nonprofit Organizations; Health Care and Treatment; Revenue; Health Industry
Heese, Jonas, Ranjani Krishnan, and Frank Moers. "Selective Regulator Decoupling and Organizations' Strategic Responses." Academy of Management Journal 59, no. 6 (December 2016). (Selected for Best Paper Proceedings of the 2015 Academy of Management Annual Meeting. Winner of the Healthcare Management Division of the Academy of Management 2015 Best Paper Award.)
- 11 Apr 2023
- Research & Ideas
Is Amazon a Retailer, a Tech Firm, or a Media Company? How AI Can Help Investors Decide
industry lines as companies increasingly bring seemingly unrelated business lines together in unconventional ways. New research by Awada, Harvard Business School Professor Suraj Srinivasan, and doctoral student Paul J. Hamilton harnesses... View Details
- September 2017 (Revised July 2023)
- Case
Adaptive Platform Trials: The Clinical Trial of the Future?
By: Ariel D. Stern and Sarah Mehta
In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details
Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States
Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Case 618-025, September 2017. (Revised July 2023.)
- 21 Feb 2018
- Research & Ideas
When a Competitor Abandons the Market, Should You Advance or Retreat?
these additional terminations are wise choices, but it helps to illustrate how the disclosure channel has a meaningful impact on competition and many millions of dollars of R&D investment decisions.” “People in the industry say, ‘Yes,... View Details
- Spring 2021
- Article
Corporate Resilience and Response During COVID-19
By: Alex Cheema-Fox, Bridget LaPerla, George Serafeim and Hui (Stacie) Wang
The coronavirus pandemic caused a sharp market decline while raising heterogeneous responses across companies related to their employees, supply chain, and repurposing of operations to provide needed products and services. We study whether during the 2020 COVID-19... View Details
Keywords: ESG; COVID-19; Coronavirus; Crisis Response Plans; Crisis; ESG (Environmental, Social, Governance) Performance; ESG Ratings; Leadership & Corporate Accountability; Big Data; Machine Learning; Investor Behavior; Institutional Investors; Corporate Performance; Health Pandemics; Crisis Management; Corporate Social Responsibility and Impact; Human Capital; Supply Chain; Operations; Leadership; Corporate Accountability; Institutional Investing; Performance
Cheema-Fox, Alex, Bridget LaPerla, George Serafeim, and Hui (Stacie) Wang. "Corporate Resilience and Response During COVID-19." Journal of Applied Corporate Finance 33, no. 2 (Spring 2021): 24–40.